Search results
24 paź 2024 · MenACWY vaccines (Menveo® and MenQuadfi®) help protect against 4 serogroups of the bacteria that cause meningococcal disease: A, C, W, and Y. This type of vaccine is also known as a serogroup A, C, W, and Y, or quadrivalent, meningococcal vaccine.
- About Meningococcal Vaccines
Currently, there are 6 meningococcal vaccines licensed and...
- About Meningococcal Vaccines
26 sty 2022 · The main vaccines used against bacterial meningitis in the United States are MenB and MenACWY. Meningitis vaccines are given on varying schedules and targeted toward certain demographics.
In June 2012, the FDA approved a combination vaccine against two types of meningococcal disease and Hib disease for infants and children 6 weeks to 18 months old. The vaccine, Menhibrix, prevents disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.
2 wrz 2022 · The Serogroup B meningococcal, or MenB, vaccine is usually recommended for adults or teens with some autoimmune conditions. It may also be recommended for those who are breastfeeding....
4 kwi 2014 · Nimenrix is a vaccine used to protect adults, adolescents and children from the age of 6 weeks against invasive meningococcal disease caused by four groups of the bacterium Neisseria meningitidis (group A, C, W-135, and Y).
Currently, there are 6 meningococcal vaccines licensed and available in the United States. Learn about the composition, types, immunogenicity, and effectiveness of these vaccines, as well as view package inserts, below.
Meningococcal meningitis is an epidemic-prone disease and there is a global emergency meningococcal vaccine stockpile managed through the International Coordinating Group (ICG) for vaccine provision for meningococcal meningitis. Defeating meningitis by 2030.
